ReePrime
Blog DMC
Janssen (Johnson & Johnson) Must Pay $70 Million In Risperdal Case

Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.

Janssen (Johnson & Johnson) Must Pay $70 Million In Risperdal Case

H
HealthFeed

446 Views • Jul 05, 2016

Description

A U.S. jury on Friday awarded $70 million to the family of a boy who developed breasts after taking Johnson & Johnson unit Janssen Pharmaceuticals' antipsychotic drug Risperdal. The jury in the Philadelphia Court of Common Pleas found that the company failed to warn the boy's healthcare providers about the risk of gynecomastia and that it intentionally falsified, destroyed, or concealed evidence in the case.

Keywords & Tags

#domesticNews #Johnson Johnson #Reuters #Haloperidol #Court #Jury #wochit #Janssen #gynecomastia #Antipsychotic #JohnsonJohnson #Risperidone #Janssen Pharmaceuticals

More from User

00:44

Dementia Diagnosis And Brain Scans

HealthFeed

00:38

Daily Naps Can Reduce Your Blood Pressure

HealthFeed

00:40

New Osteopathic Technique Helps Identify Ectopic Pregnancy

HealthFeed

00:38

Eat More Hot Chili Peppers

HealthFeed

00:41

Genetically Engineered Foods That Might be Dangerous

HealthFeed

00:37

Sex Change (Sexual Reassignment) Surgery Covered By Medicare

HealthFeed

Related Videos

00:54

Janssen (Johnson & Johnson) Must Pay $70 Million In Risperdal Case

Healthfeednews

00:30

Reuters: "Johnson & Johnson supo durante décadas que su talco para bebés tenía asbesto"

Periodista Digital

00:39

Russia Oddly Cat Rescue Reuters | Reuters reports | Viral Videos

Viral Videos

02:30

Reuters launches Reuters TV

InvestmentPitch Media

01:58

Clinical trial ng Janssen Pharmaceuticals sa bansa, nagsimula na

PTVPhilippines

04:16

Clinical trial ng COVID-19 vaccine ng Janssen Pharmaceuticals, magsisimula na ngayong linggo

PTVPhilippines